Literature DB >> 31452393

Nomograms for predicting the survival rate for cervical cancer patients who undergo radiation therapy: a SEER analysis.

Jin Yang1,2, Guoxiang Tian3, Zhenyu Pan1,2,4, Fanfan Zhao1,2, Xiaojie Feng1,2, Qingqing Liu1,2, Jun Lyu1,2.   

Abstract

Aim: To integrate multiple independent risk factors to establish prognostic nomograms for better predicting overall survival and disease-specific survival in patients with cervical cancer receiving radiation therapy. Materials & methods: Cox analysis used to construct nomograms. The C-index, time-dependent receiver operating characteristic and calibration plots were used to evaluate the performance. The discrimination abilities were compared using the decision curve analysis, net reclassification improvement and integrated discrimination improvement.
Results: After randomization, 2869 and 1230 cervical cancer patients were included in the training and validation sets, respectively. Nomograms that incorporated all of the significant independent factors for predicting the 3- and 5-year overall survival and disease-specific survival in the training cohort were established.
Conclusion: Compared with the International Federation of Gynecology and Obstetrics staging system, the proposed nomograms exhibit superior prognostic discrimination and survival prediction.

Entities:  

Keywords:  FIGO stage; SEER; cervical cancer; nomogram; radiation therapy; survival

Mesh:

Year:  2019        PMID: 31452393     DOI: 10.2217/fon-2019-0029

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  8 in total

1.  Tumor DNA Methylation Profiles Enable Diagnosis, Prognosis Prediction, and Screening for Cervical Cancer.

Authors:  Jiannan Tu; Shengchi Chen; Shizhen Wu; Ting Wu; Renliang Fan; Zhixing Kuang
Journal:  Int J Gen Med       Date:  2022-06-27

2.  Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma.

Authors:  Peng Jiang; Yuzhen Huang; Yuan Tu; Ning Li; Wei Kong; Feiyao Di; Shan Jiang; Jingni Zhang; Qianlin Yi; Rui Yuan
Journal:  Front Oncol       Date:  2021-08-04       Impact factor: 6.244

3.  Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.

Authors:  Lele Zang; Qin Chen; Xiaozhen Zhang; Xiaohong Zhong; Jian Chen; Yi Fang; An Lin; Min Wang
Journal:  Cancer Manag Res       Date:  2021-12-29       Impact factor: 3.989

4.  Prognostic Nomogram for Overall Survival of Patients Aged 50 Years or Older with Cervical Cancer.

Authors:  Jing Yan; Yue He; Ming Wang; Yumei Wu
Journal:  Int J Gen Med       Date:  2021-11-06

5.  A Survival Prediction for Acute Heart Failure Patients via Web-Based Dynamic Nomogram with Internal Validation: A Prospective Cohort Study.

Authors:  Ting Yin; Shi Shi; Xu Zhu; Iokfai Cheang; Xinyi Lu; Rongrong Gao; Haifeng Zhang; Wenming Yao; Yanli Zhou; Xinli Li
Journal:  J Inflamm Res       Date:  2022-03-20

6.  Predicting the Recurrence of Operable Cervical Cancer Patients Based on Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and Classical Clinicopathological Parameters.

Authors:  Peng Jiang; Wei Kong; Chunxia Gong; Yanlin Chen; Fenglian Li; Lingya Xu; Yang Yang; Shikai Gou; Zhuoying Hu
Journal:  J Inflamm Res       Date:  2022-09-12

7.  Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study.

Authors:  Jia-Yuan Wu; Yu-Feng Wang; Huan Ma; Sha-Sha Li; Hui-Lai Miao
Journal:  World J Gastroenterol       Date:  2020-02-07       Impact factor: 5.742

8.  Prognostic Model for Predicting Overall and Cancer-Specific Survival Among Patients With Cervical Squamous Cell Carcinoma: A SEER Based Study.

Authors:  Zhuolin Li; Yao Lin; Bizhen Cheng; Qiaoxin Zhang; Yingmu Cai
Journal:  Front Oncol       Date:  2021-07-14       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.